Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in Denmark

Analyzing the healthcare expenditure on pharmaceuticals and medical non-durable goods in Denmark from 2013 to 2023, we observe a descending trend. Starting at 0.7% of GDP in 2013, the value gradually declined to 0.64% by 2023, except for some minor fluctuations such as the rise in 2019 and 2020. Year-on-year variations reveal the most significant drops in 2016 and 2021 at -2.9% and -8.7%, respectively, alongside growth in 2019 and 2020, offset by periods of stagnation and decline. The average CAGR over the last five years indicates a slight negative trend at -0.31%.

Future trends to watch for:

• A consistent forecast at 0.63% of GDP suggests stability but no growth is expected.
• Potential external factors, such as policy changes or global health crises, could impact these forecasts.
• Advancements in pharmaceuticals and medical technology may influence future expenditure.